Cytori First Quarter Financial Results Update
Get Alerts CYTX Hot Sheet
Join SI Premium – FREE
May 11th, 2015, 5:30 PM ET
SAN DIEGO--(BUSINESS WIRE)-- Cytori Therapeutics, Inc. (NASDAQ: CYTX) will provide a live webcast of its first quarter financial results and business update on Monday, May 11, 2015, at 5:30 PM Eastern Time.
The dial-in information is as follows:
Dial-In Number: +1.877.402.3914Conference ID: 33808048
Prior to the webcast at approximately 4:05 PM Eastern Time on May 7, Cytori will issue its first quarter earnings release which will review Cytori’s first quarter performance. The webcast will be available both live and by replay two hours after the call in the “Webcasts” section of the company’s investor relations website.
About Cytori Therapeutics, Inc.
Cytori Therapeutics is a late stage cell therapy company developing autologous cell therapies from adipose tissue to treat a variety of medical conditions. Data from preclinical studies and clinical trials suggest that Cytori Cell Therapy™ acts principally by improving blood flow, modulating the immune system, and facilitating wound repair. As a result, Cytori Cell Therapy™ may provide benefits across multiple disease states and can be made available to the physician and patient at the point-of-care through Cytori’s proprietary technologies and products. For more information: visit www.cytori.com or follow Cytori on Twitter www.twitter.com/cytori.
Cytori Therapeutics, Inc.
Shawn Richardson, 858-875-5279
[email protected]
Source: Cytori Therapeutics, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi bullish on MongoDB stock, expects 'significant positive estimate revisions'
- Ambiq Reports Second Quarter 2026 Financial Results
- On Holding shares fall sharply after Q2 sales miss
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Twitter, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share